These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16922662)

  • 1. Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction? A multicentre study.
    Krum H; Meehan A; Varigos J; Loane PR; Billah B
    Med J Aust; 2006 Aug; 185(4):191-4. PubMed ID: 16922662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry.
    Juillière Y; Cambou JP; Bataille V; Mulak G; Galinier M; Gibelin P; Benamer H; Bouvaist H; Méneveau N; Tabone X; Simon T; Danchin N;
    Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):326-33. PubMed ID: 22357361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.
    Fonarow GC; French WJ; Parsons LS; Sun H; Malmgren JA
    Circulation; 2001 Jan; 103(1):38-44. PubMed ID: 11136683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia.
    Venkatason P; Zaharan NL; Ismail MD; Wan Ahmad WA; Mahmood Zuhdi AS
    Eur J Clin Pharmacol; 2018 Jul; 74(7):953-960. PubMed ID: 29582106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underutilization of beta-blockers in older patients with prior myocardial infarction or coronary artery disease in an academic, hospital-based geriatrics practice.
    Mendelson G; Aronow WS
    J Am Geriatr Soc; 1997 Nov; 45(11):1360-1. PubMed ID: 9361662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction?
    Bailey LJ; Naganathan V
    Med J Aust; 2007 Jan; 186(2):99-100; author reply 100-101. PubMed ID: 17223774
    [No Abstract]   [Full Text] [Related]  

  • 8. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker medication usage in older women after myocardial infarction.
    Crane PB; Oles KS; Kennedy-Malone L
    J Am Acad Nurse Pract; 2006 Oct; 18(10):463-70. PubMed ID: 16999711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry.
    Ajani AE; Reid CM; Duffy SJ; Andrianopoulos N; Lefkovits J; Black A; New G; Lew R; Shaw JA; Yan BP; Gurvitch R; Al-Fiadh A; Brennan AL; Clark DJ
    Med J Aust; 2008 Oct; 189(8):423-8. PubMed ID: 18928433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
    Wu AH; Parsons L; Every NR; Bates ER;
    J Am Coll Cardiol; 2002 Oct; 40(8):1389-94. PubMed ID: 12392826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study.
    Clark RA; Eckert KA; Stewart S; Phillips SM; Yallop JJ; Tonkin AM; Krum H
    Med J Aust; 2007 May; 186(9):441-5. PubMed ID: 17484704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of physicians' training on prescribing beta-blockers for secondary prevention of myocardial infarction in the elderly.
    Levy AR; Tamblyn RM; Mcleod PJ; Fitchett D; Abrahamowicz M
    Ann Epidemiol; 2002 Feb; 12(2):86-9. PubMed ID: 11880215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart-failure-complicating acute myocardial infarction.
    Aronow WS
    Clin Geriatr Med; 2007 Feb; 23(1):123-39. PubMed ID: 17126758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D; Paris BE; Aronow WS
    J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
    Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
    Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underuse of beta-blockers following myocardial infarction: a tale of two cities.
    Nicholls SJ; McElduff P; Dobson AJ; Jamrozik KD; Hobbs MS; Leitch JW
    Intern Med J; 2001; 31(7):391-6. PubMed ID: 11584900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.